1.
Gordon LI, Liu FF, Braverman J, Hoda D, Ghosh N, Hamadani M, Hildebrandt GC, Peng L, Guo S, Shi L, Sehgal A. Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study. haematol [Internet]. 2024Mar.1 [cited 2024Jun.13];109(3):857-66. Available from: https://haematologica.org/article/view/haematol.2023.283162